BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25987057)

  • 1. Regulation Roles of MICA and NKG2D in Human Renal Cancer Cells.
    Jia HY; Liu JL; Yuan MZ; Zhou CJ; Sun WD; Zhao JJ; Wang J; Liu L; Luan Y
    Asian Pac J Cancer Prev; 2015; 16(9):3901-5. PubMed ID: 25987057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of membrane/soluble MHC class I chain-related molecule A and NKG2D receptor in osteosarcoma and its clinical significance].
    Xiao P; Xue L; Che LH; Wu HX; Qiao H
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):596-9. PubMed ID: 18070447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma.
    Yang FQ; Liu M; Yang FP; Zhang XL; Yang B; Guo CC; Huang JH; Che JP; Yan Y; Zheng JH
    Actas Urol Esp; 2014 Apr; 38(3):172-8. PubMed ID: 24461475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer.
    Duan X; Deng L; Chen X; Lu Y; Zhang Q; Zhang K; Hu Y; Zeng J; Sun W
    Med Oncol; 2011 Jun; 28(2):466-74. PubMed ID: 20354827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
    Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
    J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.
    Sconocchia G; Spagnoli GC; Del Principe D; Ferrone S; Anselmi M; Wongsena W; Cervelli V; Schultz-Thater E; Wyler S; Carafa V; Moch H; Terracciano L; Tornillo L
    Neoplasia; 2009 Jul; 11(7):662-71. PubMed ID: 19568411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble major histocompatibility complex class I-related chain A protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma.
    Ma L; Li G; Su Y; He Q; Zhang C; Zhang J
    J Clin Neurosci; 2010 Feb; 17(2):241-7. PubMed ID: 20045334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.
    Arreygue-Garcia NA; Daneri-Navarro A; del Toro-Arreola A; Cid-Arregui A; Gonzalez-Ramella O; Jave-Suarez LF; Aguilar-Lemarroy A; Troyo-Sanroman R; Bravo-Cuellar A; Delgado-Rizo V; Garcia-Iglesias T; Hernandez-Flores G; Del Toro-Arreola S
    BMC Cancer; 2008 Jan; 8():16. PubMed ID: 18208618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MICA/IL-12: A novel bifunctional protein for killer cell activation.
    Tietje A; Yang X; Yu X; Wei Y
    Oncol Rep; 2017 Mar; 37(3):1889-1895. PubMed ID: 28098874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.
    Boukouaci W; Al-Daccak R; Dulphy N; Lauden L; Amokrane K; Fortier C; Marzais F; Bennabi M; Peffault de Latour R; Socie G; Toubert A; Charron D; Krishnamoorthy R; Tamouza R
    Hum Immunol; 2013 Dec; 74(12):1536-41. PubMed ID: 23994587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
    BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
    Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA
    J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.
    Bedel R; Thiery-Vuillemin A; Grandclement C; Balland J; Remy-Martin JP; Kantelip B; Pallandre JR; Pivot X; Ferrand C; Tiberghien P; Borg C
    Cancer Res; 2011 Mar; 71(5):1615-26. PubMed ID: 21257710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.